Search Results 601-610 of 8022 for TNF
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
This study will evaluate the safety of intramuscular administration of PLX-R18 (allogenetic ex-vivo explanded placental adherent stromal cells) in subjects who ...
Read news articles related to T cell therapy using genomics data from the T Cell Engineering Lab of Saad J. Kenderian, M.B., Ch.B., at Mayo Clinic.
What is the incidence and etiology of bone overgrowth in protein versus other bone graft? Participation eligibility. Participant eligibility includes age, ...
Graduate students and research fellows interested in the mechanisms and biology of age-related neurodegenerative disorders as well as translation of knowledge ...
About this study. This study is intended to obtain clinical information and establish a repository of DNA, RNA, peripheral blood monocyte, lymphocyte and ...
Translational Neuroimmunology Laboratory of Charles L. Howe, Ph.D., at Mayo Clinic: Researches circuitry of acute neuroinflammatory disorders.
About this study. Participants with heart failure with preserved ejection fraction will undergo 12 weeks of cardiac rehabilitation for exercise training ...
The purpose of tis first-in-human study is to evaluate the safety, tolerability, pharmacokinetics, and antitumor activity of TORL-1-23 in patients with advanced ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.